Vireo Growth Inc. (VREOF) stock

VREOFOTCPharmaceutical PreparationsFiscal year ends December 31

Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 12, 2026Score 11/30

$9.01+0.01 (+0.11%)

Close on Oct 19, 2026Market cap $443.48MP/E –Yield –

Vireo Growth EV/EBITDA

EV/EBITDA is enterprise value divided by EBITDA over the trailing twelve months.

Vireo Growth's EV/EBITDA was 8.9× on Oct 19, 2026, against 17.1× a year earlier. Over the last 3 years it ranged from 1.0× to 46.9×, with a median of 5.2×.

EV/EBITDA at the end of each year

Period	Period end	Value	Change (pts)
2026	Oct 19, 2026	8.9×	−38.0
2025	Dec 31, 2025	46.9×	+43.3
2024	Dec 31, 2024	3.6×	+1.6
2023	Dec 29, 2023	2.0×	–

Where these numbers come from

Parsed from the XBRL in Vireo Growth's annual and quarterly filings with the SEC
Per-share figures adjusted for the 1-for-30 reverse split on Jun 5, 2026
Fourth quarters derived from the annual report minus nine months
Every figure in the statements links to its source filing